| Barchart Demo Center |
$4.18
-0.31 (-6.90%)
as of Dec 6, 2019
as of Dec 6, 2019
| Last | 4.18 |
|---|---|
| Change | -0.31 (-6.90%) |
| Open | 4.60 |
| Prev. Close | 4.49 |
| Today's Range |
4.16
4.60
|
| 52wk Range |
4.16
15.89
|
| Volume | 43,600 |
| Avg Volume | 58,350 |
| Sector | SIC-2834 Pharmaceutical Preparations |
Perfomance Comparison
| Name | Today | 3-Month | 1-Year |
|---|---|---|---|
| EVLO |
 -6.90% |
 -30.91% |
-61.33% |
| DJIA |
 +1.22% |
 +4.18% |
+12.30% |
| S&P 500 |
+0.91% |
+5.65% |
+16.69% |
Key Statistics
| Annual EPS | -2.45 |
|---|---|
| Dividend Yield | 0.00% |
| P/E Ratio | N/A |
| Market Capitalization, $K | 144,230 |
| Weighted Alpha | -69.50 |
| Standard Deviation | -2.42 |
| Profit Margin | N/A |
| Beta | -0.33 |
Growth Rates
| YTD | -67.87% | |||
| 1-Year | -54.27% |
Opinion
| Sell | Hold | Buy |
Recent Headlines
Evelo Biosciences Appoints Juan Andres to Board of
GlobeNewswire via COMTEX - Thu Dec 05, 07:00AM EST
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced the appointment of biopharmaceutical industry veteran Juan(full story)
Flagship Pioneering Names Dr. Nancy Simonian, CEO of
PR Newswire via COMTEX - Mon Dec 02, 01:51PM EST
Flagship Pioneering has announced the recipient of the firm's annual Pioneering Leader Award. The 2019 award recognizes Nancy Simonian, M.D., CEO of Syros Pharmaceuticals (NASDAQ: SYRS), a company that is redefining the power of s(full story)
AXLA: 3.59 (-0.90), DNLI: 18.26 (+0.08), EVLO: 4.18 (-0.31), KLDO: 5.36 (-1.06), MRNA: 18.94 (-1.70), RUBY: 10.62 (+0.28), MCRB: 3.67 (-0.01)
Evelo Biosciences to Present at the Stifel 2019
GlobeNewswire via COMTEX - Wed Nov 13, 08:01AM EST
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that management will present a corporate overview at the S(full story)
EVLO: 4.18 (-0.31)
Flagship Pioneering Appoints Prakash Raman, Ph.D. as
PR Newswire via COMTEX - Tue Nov 12, 08:00AM EST
Flagship Pioneering, a unique life sciences innovation enterprise, today announced the appointment of Prakash Raman, Ph.D. to the post of Senior Partner and the newly created role of Chief Business Development Officer. Dr. Raman m(full story)
NVS: 92.07 (+0.43), AXLA: 3.59 (-0.90), DNLI: 18.26 (+0.08), EVLO: 4.18 (-0.31), KLDO: 5.36 (-1.06), MRNA: 18.94 (-1.70), RUBY: 10.62 (+0.28)
Evelo Biosciences to Present Preclinical Data from its
GlobeNewswire via COMTEX - Fri Nov 08, 07:00AM EST
Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that preclinical data from its oncology program, EDP1503, will b(full story)
EVLO: 4.18 (-0.31)